NZ701190A - Combination meloxicam and xylazine therapy in animals - Google Patents
Combination meloxicam and xylazine therapy in animalsInfo
- Publication number
- NZ701190A NZ701190A NZ701190A NZ70119013A NZ701190A NZ 701190 A NZ701190 A NZ 701190A NZ 701190 A NZ701190 A NZ 701190A NZ 70119013 A NZ70119013 A NZ 70119013A NZ 701190 A NZ701190 A NZ 701190A
- Authority
- NZ
- New Zealand
- Prior art keywords
- meloxicam
- xylazine
- combination
- animals
- therapy
- Prior art date
Links
- BPICBUSOMSTKRF-UHFFFAOYSA-N xylazine Chemical compound CC1=CC=CC(C)=C1NC1=NCCCS1 BPICBUSOMSTKRF-UHFFFAOYSA-N 0.000 title abstract 4
- 229960001600 xylazine Drugs 0.000 title abstract 4
- 229940038665 combination meloxicam Drugs 0.000 title abstract 2
- 241001465754 Metazoa Species 0.000 title 1
- 238000002560 therapeutic procedure Methods 0.000 title 1
- 239000000203 mixture Substances 0.000 abstract 5
- 238000009472 formulation Methods 0.000 abstract 4
- ZRVUJXDFFKFLMG-UHFFFAOYSA-N Meloxicam Chemical compound OC=1C2=CC=CC=C2S(=O)(=O)N(C)C=1C(=O)NC1=NC=C(C)S1 ZRVUJXDFFKFLMG-UHFFFAOYSA-N 0.000 abstract 3
- 229960001929 meloxicam Drugs 0.000 abstract 3
- 238000000034 method Methods 0.000 abstract 2
- 241000283690 Bos taurus Species 0.000 abstract 1
- 241001494479 Pecora Species 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 241000894007 species Species 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/5415—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with carbocyclic ring systems, e.g. phenothiazine, chlorpromazine, piroxicam
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Nutrition Science (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Rheumatology (AREA)
- Neurosurgery (AREA)
- Anesthesiology (AREA)
- Physiology (AREA)
- Pain & Pain Management (AREA)
- Dispersion Chemistry (AREA)
- Inorganic Chemistry (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2012901666A AU2012901666A0 (en) | 2012-04-27 | Combination of meloxicam and xylazine therapy in animals | |
PCT/AU2013/000429 WO2013159151A1 (en) | 2012-04-27 | 2013-04-26 | Combination meloxicam and xylazine therapy in animals |
Publications (1)
Publication Number | Publication Date |
---|---|
NZ701190A true NZ701190A (en) | 2016-07-29 |
Family
ID=49482035
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NZ701190A NZ701190A (en) | 2012-04-27 | 2013-04-26 | Combination meloxicam and xylazine therapy in animals |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP2841072A4 (en) |
AU (3) | AU2013252491A1 (en) |
NZ (1) | NZ701190A (en) |
WO (1) | WO2013159151A1 (en) |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NL8702523A (en) * | 1986-11-03 | 1988-06-01 | Sandoz Ag | PHARMACEUTICAL PREPARATIONS WITH ANALGETIC ACTION AND METHOD FOR PREPARING OR PREPARING AND USING THESE PREPARATIONS. |
ES2490595T3 (en) * | 2005-02-17 | 2014-09-04 | Abbott Laboratories | Transmucosal administration of drug compositions to treat and prevent disorders in animals |
WO2007072503A2 (en) * | 2005-12-21 | 2007-06-28 | Panacea Biotec Ltd. | Combinations for managing inflammation and associated disorders |
UY30636A1 (en) * | 2006-10-18 | 2008-05-02 | Senosiain Lab | PHARMACEUTICAL COMPOSISION OF MODIFIED LIBERATION OF A RELAXING MUSCLE AND AN NSAID |
EP2329849B1 (en) * | 2009-11-18 | 2015-04-29 | Galderma Research & Development | Combination of alpha-2 adrenergic receptor agonist and non-steroidal anti-inflammatory agent for treating or preventing an inflammatory skin disorder |
US8791105B2 (en) * | 2010-07-14 | 2014-07-29 | Kansas State University Research Foundation | Methods for alleviating chronic pain and improving performance of cattle undergoing dehorning or castration |
-
2013
- 2013-04-26 EP EP13781843.1A patent/EP2841072A4/en not_active Withdrawn
- 2013-04-26 NZ NZ701190A patent/NZ701190A/en unknown
- 2013-04-26 AU AU2013252491A patent/AU2013252491A1/en not_active Abandoned
- 2013-04-26 WO PCT/AU2013/000429 patent/WO2013159151A1/en active Application Filing
-
2017
- 2017-08-10 AU AU2017101084A patent/AU2017101084B4/en not_active Ceased
-
2018
- 2018-02-12 AU AU2018201002A patent/AU2018201002A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
AU2018201002A1 (en) | 2018-03-01 |
AU2017101084A4 (en) | 2017-09-07 |
WO2013159151A1 (en) | 2013-10-31 |
AU2017101084B4 (en) | 2017-11-02 |
AU2013252491A1 (en) | 2014-11-06 |
EP2841072A1 (en) | 2015-03-04 |
EP2841072A4 (en) | 2016-01-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2018015892A (en) | Boronic acid derivatives and therapeutic uses thereof. | |
MX2021015234A (en) | Compositions and methods comprising bupropion or related compounds and dextromethorphan. | |
EA201691988A1 (en) | DERIVATIVES OF BORONIC ACID AND THEIR THERAPEUTIC APPLICATION | |
BR112014024833A8 (en) | VETERINARY SOFT CHEWABLE PHARMACEUTICAL PRODUCT, PROCESS FOR MANUFACTURING A PRODUCT, USE OF PAMOIC ACID OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, USE OF A SOFT CHEWABLE VETERINARY PHARMACEUTICAL COMPOSITION, AND, SOFT CHEWABLE VETERINARY PHARMACEUTICAL COMPOSITION. | |
EA201692301A1 (en) | DERIVATIVES OF BORONIC ACID AND THEIR THERAPEUTIC APPLICATION | |
MD4577C1 (en) | Chewable veterinary compositions comprising an isoxazoline active agent and their use in the treatment and/or prophylaxis of a parasitic infection and infestation | |
MX2016004035A (en) | Long-acting spiro-isoxazoline formulations. | |
EA201591003A1 (en) | DERIVATIVES OF BORONIC ACID AND THEIR THERAPEUTIC APPLICATION | |
MX2013011086A (en) | (alpha- substituted aralkylamino and heteroarylalkylamino) pyrimidinyl and 1,3,5 -triazinyl benzimidazoles, pharmaceutical compositions containing them, and these compounds for use in treating proliferative diseases. | |
PE20150199A1 (en) | PHARMACEUTICAL COMPOSITIONS AND TREATMENT OF MASTITIS | |
EA201690386A1 (en) | COMPOUNDS AND COMPOSITIONS AS MEK INHIBITORS | |
MX2022015141A (en) | Compositions and methods of use of an inappetance-controlling compound. | |
NZ706990A (en) | A veterinary method of alleviating noise aversion | |
BR112013010136A2 (en) | vaccine, therapeutic composition and methods for the treatment or inhibition of gliblastoma | |
BR112015022846A2 (en) | use of a compound to treat or prevent a bradykinin b2 receptor mediated angioedema and formulation comprising the same | |
MX2019006773A (en) | Dexmedetomidine or medetomidine for use in treating separation anxiety in dogs. | |
PH12014502065A1 (en) | Vesicular formulations | |
EA201390345A1 (en) | THERAPEUTIC HOSE MEDICINE | |
UA117751C2 (en) | Tylosin derivatives and method for preparation thereof | |
BR112015032262A2 (en) | nanoparticle compositions and piperazine compound formulations | |
TR201908936T4 (en) | Use of palmitoylethanolamide in combination with opioids. | |
EA201590097A1 (en) | COMPOSITIONS WITH SINGLE DOSE FOR ORAL ADMINISTRATION AND METHODS OF TREATING CATS WITH THE HELP OF SPINOSADE DESTROYING ECT PARASITES | |
NZ701190A (en) | Combination meloxicam and xylazine therapy in animals | |
NZ717434A (en) | A veterinary method for inducing emesis | |
EA201500014A1 (en) | MEANS FOR TREATING COCKIDIOSIS IN BIRDS AND ANIMALS |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PSEA | Patent sealed | ||
RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 26 APR 2018 BY PETER MAXWELL + ASSOCIATES Effective date: 20170407 |
|
RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 26 APR 2019 BY PETER MAXWELL + ASSOCIATES Effective date: 20180201 |
|
RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 26 APR 2020 BY PETER MAXWELL + ASSOCIATES Effective date: 20190212 |
|
RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 26 APR 2021 BY PETER MAXWELL + ASSOCIATES Effective date: 20200218 |
|
RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 26 APR 2022 BY MAXWELLS PATENT + TRADE MARK ATTORNEYS PTY LTD Effective date: 20210531 |
|
RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 26 APR 2023 BY MAXWELLS PATENT + TRADE MARK ATTORNEYS PTY LTD Effective date: 20220419 |
|
RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 26 APR 2024 BY GRIFFITH HACK Effective date: 20231025 |